Salvage Breast-Conserving Surgery and Reirradiation With Intraoperative Electrons for Recurrent Breast Cancer: A Multicentric Study on Behalf of Italian Association of Radiotherapy and Clinical Oncology (AIRO)
- Creators
- Leonardi M. C.
- Fodor A. D.
- Frassoni S.
- Rojas D. P.
- Fozza A.
- Blandino G.
- Ciabattoni A.
- Alessandro M.
- Catalano G.
- Ivaldi G. B.
- Martini S.
- De Rose F.
- Fodor C.
- Veronesi P.
- Galimberti V. E.
- Intra M.
- Cornacchia L.
- Braga F.
- Durante S.
- Dicuonzo S.
- Morra A.
- Zaffaroni M.
- Cattani F.
- Belgioia L.
- Palumbo I.
- Massaccesi M.
- Bagnardi V.
- Orecchia R.
- Jereczek-Fossa B. A.
- Others:
- Leonardi, M. C.
- Fodor, A. D.
- Frassoni, S.
- Rojas, D. P.
- Fozza, A.
- Blandino, G.
- Ciabattoni, A.
- Alessandro, M.
- Catalano, G.
- Ivaldi, G. B.
- Martini, S.
- De Rose, F.
- Fodor, C.
- Veronesi, P.
- Galimberti, V. E.
- Intra, M.
- Cornacchia, L.
- Braga, F.
- Durante, S.
- Dicuonzo, S.
- Morra, A.
- Zaffaroni, M.
- Cattani, F.
- Belgioia, L.
- Palumbo, I.
- Massaccesi, M.
- Bagnardi, V.
- Orecchia, R.
- Jereczek-Fossa, B. A.
Description
Purpose: Intraoperative radiation therapy with electrons (IOERT) may represent a viable choice for partial breast reirradiation after repeat quadrantectomy for local recurrence (LR) for primary breast cancer (BC) in lieu of mastectomy. Methods and materials: A database collecting data on partial breast reirradiation with IOERT from 8 Italian centers was set up in 2016 to 2018, providing data on cumulative incidence (CumI) of second LR and survival with a long follow-up. Results: From 2002 to 2015, 109 patients underwent the conservative retreatment. The median primary BC first LR interval was 11.1 years (range, 2.4-27.7). The median first LR size was 0.9 cm (range, 0.3-3.0), and 43.6% cases were luminal A. Median IOERT dose was 18 Gy (range, 12-21), and median collimator diameter was 4 cm (range, 3-6). Median follow-up duration was 11.7 years (IQR, 7.7-14.6). The second LR CumI was 12.2% (95% CI, 6.8%-19.2%) at 5 years and 32.3% at 10 years (95% CI, 22.8%-42.2%), occurring in the same site as the first LR in about half of the cases. Human epidermal growth factor receptor 2 status and collimator size were independent LR predictors. The 5- and 10-year overall survival rates were 95.2% and 88.3%, respectively, whereas 5- and 10-year BC-specific survival rates were 98% and 94.5%, respectively. The development of a second LR significantly reduced BC-specific survival (hazard ratio, 9.40; P < .001). Grade ≥3 fibrosis rate was 18.9%. Patient-reported cosmesis was good/excellent in 59.7% of the cases. Conclusions: Second LR CumI was within the range of the literature but higher than expected, opening questions on radiation field extension and fractionation schedule. Because a second LR worsened the outcome, salvage modality must be carefully planned.
Additional details
- URL
- https://hdl.handle.net/11567/1208515
- URN
- urn:oai:iris.unige.it:11567/1208515
- Origin repository
- UNIGE